Literature DB >> 11257763

[Sentinel node detection of patients with breast cancer by radionuclide method: consideration of radiation safety].

M Koizumi1, E Nomura, Y Yamada, T Takiguchi, K Takahashi, T Tada, M Saito, K Uchida, M Makita, M Yoshimoto, F Kasumi, T Takahashi, N Sekine, E Ogata.   

Abstract

Sentinel node was detected by 99mTc labeled nanocolloid in five patients with breast cancer. Surgery of breast cancer was done at 16 hours after the administration of 74 MBq of 99mTc labeled nanocolloid. Sentinel node was searched by scintigraphy prior to surgery and by gamma-probe during surgery. Radioactivity of injected site, sentinel nodes, blood contaminated gauze, and other garbage was measured by GM detector. Radiation to medical staffs was monitored by a pocket radiation detector and film batches. Sentinel nodes were successfully detected both by scintigraphy and gamma-detector. More than 70% of radioactivity remained in the administered site at 16 hours. Small amount of radioactivity was detectable in the sentinel node. Almost no radioactivity was detectable in blood-contaminated gauze and other garbage. Radiation dose to the main surgeon was 4 to 6 microSv per surgery by a pocket radiation detector. Radiation dose to the assistant surgeon was 2 microSv per surgery. Radiation dose by labeling or injection was 0 to 1 microSv per procedure. No detectable radiation was measured by film batches. It is concluded that the detection of sentinel node by 99mTc labeled nanocolloid is a safe procedure from the point of radiation safety consideration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11257763

Source DB:  PubMed          Journal:  Kaku Igaku        ISSN: 0022-7854


  1 in total

1.  Moving a neodymium magnet promotes the migration of a magnetic tracer and increases the monitoring counts on the skin surface of sentinel lymph nodes in breast cancer.

Authors:  Masujiro Makita; Eriko Manabe; Tomoko Kurita; Hiroyuki Takei; Seigo Nakamura; Akihiro Kuwahata; Masaki Sekino; Moriaki Kusakabe; Yasuo Ohashi
Journal:  BMC Med Imaging       Date:  2020-05-27       Impact factor: 1.930

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.